ArticleMedical principles and practice : international journal of the Kuwait University, Health Science Centre2026
The Challenge of Hypophosphatasia Diagnosis in Patients with Fibromyalgia.
Article in Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Persistently Low Alkaline Phosphatase in Fibromyalgia: Hypophosphatasia or Confounding Clinical Context?Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2026Article
- Interpreting Low Alkaline Phosphatase in Fibromyalgia: The Importance of Comprehensive Clinical and Biochemical Assessment.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveRecent reports suggest that mild forms of hypophosphatasia (HPP) may be misdiagnosed as fibromyalgia (FM), thus exposing patients to potential complications (e.g., fractures). It seems reasonable to determine alkaline phosphatase (ALP) levels in all patients diagnosed with FM. We aimed to study this clinical recommendation by assessing the prevalence of HPP in a cohort of patients diagnosed with FM in a specialized unit. SUBJECTS AND
methodsThis retrospective study (2014-2021) included 713 patients with FM and previous determinations of ALP levels from a Multidisciplinary Fibromyalgia Unit of a Rheumatology Department. Medical records (ALP levels, history of fractures, radiologic studies, pharmacological treatment, and comorbidities) were reviewed. Patients with at least two ALP determinations under normal values were further evaluated with a study of bone metabolic parameters, ALP substrate [PLP: pyridoxal-5'-phosphate] and genetic testing for alkaline phosphatase, liver/bone/kidney (ALPL) pathogenic variants.
results16 (3.2%) FM patients (all women with a median age of 50 years) showed low ALP levels. Notably, 5 patients (31.3%) also showed elevated PLP levels, suggesting HPP. However, none presented pathogenic ALPL variants in the genetic study. Other associated conditions, such as subclinical hypothyroidism and the use of dietary supplements/multivitamins, were observed in some of these patients.
conclusionIn the present cohort, 3.2% presented persistently decreased ALP levels. The increased ALPL substrate, PLP, observed in one third of these subjects, together with the negative genetic study in all these subjects, indicate the need to better identify the subjects with FM that may have mild forms of HPP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.